Peer Review reports
From: Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy
| Original Submission | ||
|---|---|---|
| 26 Oct 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 29 Dec 2021 | Reviewed | Reviewer Report |
| 10 Jan 2022 | Reviewed | Reviewer Report |
| 7 Feb 2022 | Author responded | Author comments - Wei-Bo Le |
| Resubmission - Version 4 | ||
| 7 Feb 2022 | Submitted | Manuscript version 4 |
| 25 Feb 2022 | Author responded | Author comments - Wei-Bo Le |
| Resubmission - Version 5 | ||
| 25 Feb 2022 | Submitted | Manuscript version 5 |
| 24 Mar 2022 | Reviewed | Reviewer Report |
| 6 Apr 2022 | Author responded | Author comments - Wei-Bo Le |
| Resubmission - Version 6 | ||
| 6 Apr 2022 | Submitted | Manuscript version 6 |
| 8 Apr 2022 | Author responded | Author comments - Wei-Bo Le |
| Resubmission - Version 7 | ||
| 8 Apr 2022 | Submitted | Manuscript version 7 |
| Publishing | ||
| 11 Apr 2022 | Editorially accepted | |
| 10 May 2022 | Article published | 10.1186/s12882-022-02814-7 |
You can find further information about peer review here.